AGM/EGMApr 28, 2026, 04:09 PM
BOLT 2026 Annual Meeting on June 10; Director Elections
AI Summary
Bolt Biotherapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, at 11:00 a.m. Pacific Time. Stockholders of record as of April 22, 2026, will vote on the election of two Class II directors, William P. Quinn and Jakob Dupont, M.D., and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. The company also noted a 1-for-20 reverse stock split was effected on June 6, 2025.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.
- Record date for voting at the Annual Meeting is April 22, 2026.
- Stockholders to vote on the election of two Class II directors.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
- Company effected a 1-for-20 reverse stock split on June 6, 2025.
- 1,921,567 shares of common stock outstanding on record date.
- Quorum requires 1/3 of the voting power of outstanding shares.